Betsabeh Khoramian Tusi

Betsabeh Khoramian Tusi is a Principal Scientist at Garuda Therapeutics since April 2024, contributing to the development of off-the-shelf hematopoietic stem cell therapies for severe diseases. Prior to this role, Betsabeh served as a Senior Scientist at SalioGen Therapeutics, focusing on non-viral gene delivery for allogeneic CAR T cells, and at Rubius Therapeutics, working on engineered red blood cell therapies for cancer and autoimmune diseases. Betsabeh's earlier experience includes research positions at Harvard Medical School, the University of Massachusetts, and the University of Florida, specializing in the genetic regulation of immunity, blood stem cell differentiation, and epigenetic mechanisms in hematopoiesis. Educational qualifications include a PhD in Molecular Medicine from Università degli Studi di Milano, an MSc in Cell & Molecular Biology from the University of Tehran, and a BSc in Genetics from the University of Ahvaz.